Manufacturing and Production

Showing 15 posts of 5867 posts found.

rocheroof

Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer

March 20, 2018 Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
upper-body-944557_960_720

Vertex “astonished” by NHS England’s response to CF drug

March 20, 2018 Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …
john_mchutchison

New Chief Science and Medical Officers for Gilead

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Working Life: Chris Round, Head of EMEA Region, Merck KGaA

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
shutterstock_57369385

India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust

March 19, 2018 Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma

India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …
12_rare

The need for flexible appraisal of rare disease medicines

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
humacao_exterior

BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey

March 15, 2018 Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma

Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …
william_pao

Roche appoints new research and early development head

March 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
biocon-k8tc--621x414livemint

FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility

March 13, 2018 Manufacturing and Production Biocon, CGMP, FDA, pharma

Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …
fda_building_web

Adaxis-AZ immunotherapy combo hit by clinical hold after death

March 13, 2018 Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical

Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …
shutterstock_159488225

Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%

March 13, 2018 Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure

Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …
novartis_side_building

Novartis reshuffle begins under new CEO

March 13, 2018 Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical

It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …
biology-think-networking-physiology-brain-anatomy-2676370

Pfizer begins sell-off, shedding CNS drug to Biogen for $590m

March 13, 2018 Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …
The Gateway to Local Adoption Series

Latest content